Yin F, Li JJ, Cao F, Yao SK. Fufang Banmao Capsules improve immunological status in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolization.
Shijie Huaren Xiaohua Zazhi 2011;
19:1843-1846. [DOI:
10.11569/wcjd.v19.i17.1843]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the impact of the traditional Chinese medicine Fufang Banmao Capsules on immunological status in patients with hepatocellular carcinoma (HCC) before and after transcatheter arterial chemoembolization (TACE).
METHODS: Fufang Banmao Capsules were administered to HCC patients before TACE or 1 wk or 1 mo after TACE. The proportions of CD4+ and CD8+ cell subsets, NK cells, and serum levels of ALT, AST, TBIL were measured 4 week after treatment.
RESULTS: The proportions of CD4+ and NK cells were lower and that of CD8+ cells was higher in HCC patients than in healthy persons (both P < 0.05). After 1 wk or 1 mo of TACE therapy, the proportions of CD4+ and NK cells were increased (33.1 ± 7.5, 38.9 ± 7.8 vs 27.1 ± 5.6; 15.9 ± 3.7, 17.9 ± 5.3 vs 10.6 ± 4.7, all P < 0.05) and those of CD8+ cells were decreased (29.9 ± 3.2, 28.7 ± 6.5 vs 34.8 ± 5.6, both P < 0.05) compared to pretreatment values. The proportions of CD4+ and NK cells were significantly higher and that of CD8+ cells was significantly lower in patients treated with Fufang Banmao Capsules for 1 month after TACE therapy than in those not receiving Fufang Banmao Capsules after TACE therapy (all P < 0.05).
CONCLUSION: The cellular immunological functions were inhibited in patients with HCC. TACE could reverse the immune suppression state in patients with HCC. The combination of TACE and Fufang Banmao Capsules could remarkably improve immunological functions in HCC patients.
Collapse